SG Americas Securities
ACOR

SG Americas Securities’s Acorda Therapeutics ACOR Stock Holding History

SG Americas Securities’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-204
Closed -$13K – 3526
2020
Q3 		$13K Sell
204
-24
-11% -$1.81K ﹤0.01% 2579
2020
Q2 		$20K Buy
228
+84
+58% +$8.88K ﹤0.01% 3605
2020
Q1 		$16K Buy
144
+25
+21% +$4.92K ﹤0.01% 3322
2019
Q4 		$29K Sell
119
-220
-65% -$55.5K ﹤0.01% 3123
2019
Q3 		$117K Buy
+339
New +$184K ﹤0.01% 2656
2019
Q2 		– Sell
-196
Closed -$313K – 3531
2019
Q1 		$313K Buy
196
+95
+94% +$171K ﹤0.01% 2235
2018
Q4 		$189K Buy
+101
New +$220K ﹤0.01% 2420
2017
Q4 		– Sell
-40
Closed -$114K – 3754
2017
Q3 		$114K Sell
40
-69
-63% -$182K ﹤0.01% 3104
2017
Q2 		$258K Buy
109
+12
+12% +$23.8K ﹤0.01% 2256
2017
Q1 		$245K Sell
97
-119
-55% -$343K ﹤0.01% 2303
2016
Q4 		$487K Buy
216
+138
+177% +$328K ﹤0.01% 1720
2016
Q3 		$196K Buy
+78
New +$233K ﹤0.01% 2515
2015
Q4 		– Sell
-51
Closed -$161K – 3055
2015
Q3 		$161K Buy
51
+21
+70% +$81.4K ﹤0.01% 1586
2015
Q2 		$120K Sell
30
-8
-21% -$30.9K ﹤0.01% 2260
2015
Q1 		$152K Sell
38
-108
-74% -$495K ﹤0.01% 2042
2014
Q4 		$716K Buy
146
+94
+181% +$403K ﹤0.01% 1410
2014
Q3 		$213K Buy
+52
New +$195K ﹤0.01% 1961
2014
Q1 		– Sell
-33
Closed -$116K – 2849
2013
Q4 		$116K Sell
33
-35
-51% -$136K ﹤0.01% 2333
2013
Q3 		$280K Buy
+68
New +$293K ﹤0.01% 1960

Other funds holding ACOR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SG Americas Securities's ACOR Position: Q4 2020 in Review

SG Americas Securities sold out of Acorda Therapeutics (ACOR) in Q4 2020, closing a stake of 204 shares — an estimated $13K sold.

SG Americas Securities first reported a position in ACOR in Q3 2013 and held it in 19 quarters. The position peaked at $716K in Q4 2014. 47 funds tracked by Wall St. Rank hold ACOR as of Q4 2020.

  • SG Americas Securities reported no remaining Acorda Therapeutics position as of Q4 2020 after selling out during the quarter.
  • SG Americas Securities sold 204 Acorda Therapeutics shares in Q4 2020, an estimated $13K.
  • SG Americas Securities first reported a position in Acorda Therapeutics in Q3 2013 and held it in 19 quarters.
  • SG Americas Securities's Acorda Therapeutics position peaked at $716K in Q4 2014.
  • 47 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2020.

Based on SG Americas Securities's 13F filing for Q4 2020, filed 4 Feb 2021.